Skip to main content

Table 1 Malignant lymphomas in women diagnosed by sentinel lymph node biopsies during breast cancer surgery

From: Follicular lymphoma without lymphadenopathy incidentally diagnosed by sentinel lymph node biopsy during breast cancer surgery: a case report

Characteristics

Report no.

1

2

3

4

Age (y)

74

67

60

73

Breast cancer indicators

pT1cN0M0

pT1cN0M0

pT1bN0M0

pT1cN0M0

 Stage

IA

IA

IA

IA

Surgery

Bp + SNLB

Bp + SNLB

Bp + SNLB

Bt + SNLB

Histology

ILC

IDC

IDC

IDC

Breast cancer subtype

ER + /PgR + /HER2−

ER−/PgR−/HER2 + 

ER−/PgR−/HER2 + 

ER + /PgR + /HER2−

Adjuvant therapy for breast cancer

Radiotherapy followed by AI

Trastuzumab with R-DHAP

Trastuzumab

AI

Lymphadenopathy in preoperative images

None

Axillary lymph node

None

None

Lymphoma stage

I

IV

III

I

 Subtype

FL

MCL

FL

FL

 Therapy

None

R-CHOP then

R-DHAP

R-CHOP

None

Priority for PT

Breast cancer

MCL

FL

Breast cancer

Year published

2010

2016

2019

2022

References

[5]

[2]

[3]

Present study

  1. AI aromatase inhibitor, Bp breast partial mastectomy, Bt breast total mastectomy, FL follicular lymphoma, HER2 human epidermal growth factor receptor type2, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, MCL mantle cell lymphoma, PT postoperative treatment, R-CHOP rituximab, cyclophosphamide, doxorubicin hydrochloride, oncovin, and prednisolone, R-DHAP rituximab, dexamethasone, high-dose ara-C, cytarabine, and cisplatin, SNLB sentinel lymph node biopsy, TNBC triple-negative breast cancer